Email updates

Keep up to date with the latest news and content from Italian Journal of Pediatrics and BioMed Central.

Open Access Case report

Interleukin 12 receptor deficiency in a child with recurrent bronchopneumonia and very high IgE levels

Loredana Palamaro1, Giuliana Giardino1, Francesca Santamaria1, Rosa Romano1, Anna Fusco1, Silvia Montella1, Mariacarolina Salerno1, Matilde Valeria Ursini2 and Claudio Pignata13*

Author Affiliations

1 Department of Pediatrics, “Federico II” University, Naples, Italy

2 International Institute of Genetics and Biophysics, CNR, Naples, Italy

3 Unit of Immunology, Department of Pediatrics, “Federico II” University, Via S. Pansini 5-80131, Naples, 80127, Italy

For all author emails, please log on.

Italian Journal of Pediatrics 2012, 38:46  doi:10.1186/1824-7288-38-46

The electronic version of this article is the complete one and can be found online at: http://www.ijponline.net/content/38/1/46


Received:1 September 2012
Accepted:14 September 2012
Published:19 September 2012

© 2012 Palamaro et al.; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Interleukin-12 (IL-12) is involved in cellular immune responses against intracellular pathogens by promoting the generation of T naive in T helper 1 (Th1) cells and by increasing interferon-gamma (IFN-gamma) production from T and natural killer (NK) cells. A defective induction of a Th1 response may lead to a higher risk of infections, and, in particular, infections due to typical and atypical Mycobacteria. We report on the case of a girl with suffering from recurrent bronchopneumonia associated with very high serum IgE levels, who exhibited a profound impairment of the Th1 generation associated with a novel mutation in the exon 5 of the IL-12R β1 gene (R156H). Our data suggest that in children with severe and recurrent infections, even in the absence of a mycobacterial infection, functional and/or genetic alterations of the molecular mechanisms governing Th1/Th2 homeostasis might be responsible for an atypical immunodeficiency and, therefore, should be investigated in these patients.

Keywords:
Immunodeficiency; IL-12/IL-12 receptor; Recurrent pneumonia

Background

Primary congenital immunodeficiencies encompass a wide spectrum of distinct clinical entities, which differ in either pathogenetic mechanism or clinical features. Recently, several novel syndromes with unusual phenotypes have been described [1,2]. However, in a number of patients suffering from severe and sometimes life-threatening infections, in which an immunological disorder is suspected, the underlying genetic defect responsible for the immunodeficiency still remains to be elucidated [3]. Recently, a higher susceptibility to intracellular pathogens and, in particular, atypical mycobacterial and salmonella infections has been described in patients with genetic alterations of the IL-12 receptor (IL-12R) [4-9]. IL-12 stimulates cellular immune responses against intracellular pathogens by promoting the generation of T naive in T helper 1 (Th1) cells and by increasing interferon-gamma (IFN-gamma) production from T and natural killer (NK) cells. Induction of a Th1 response and cell cycle progression mostly relies on the expression of a high affinity IL-12R, consisting of β1 and β2 chains [10-15]. A few genetic alterations of β1 chain have already been reported in patients suffering of mycobacterial infections [5,6].

Case presentation

A 8-year-old girl was referred to the our Department because of a history of recurrent pneumonia (4 episodes over 2 years). At the age of 4 years and 8 months she had suffered from the first episode of middle lobar bronchopneumonia requiring hospitalization. In that occasion the total IgE serum levels were 3350 kU/l. One month later, she was hospitalized for a second bronchopneumonia episode interesting both lungs followed by persistent cough for more than a month. These episodes were responsive to antibiotic therapy. Subsequently, she had suffered from 2 additional bronchopneumonia episodes in distinct lung area, successfully treated with parenteral antibiotic therapy. Conventional x-ray and high resolution computed tomography of the chest revealed multiple focal consolidations in both lungs, confirmed by magnetic resonance imaging [16]. Acid resistant bacillus was not found in the sputum examination. In one occasion, Haemophilus influenzae was isolated on sputum culture. Weight and height growth was in the normal range. No infections in other organs were reported. The routine immunological evaluation revealed normal IgG and IgA, but very high serum IgE levels (> 2000 kU/l), confirmed in several occasions during the 2 years follow-up. Specific IgE toward Dermatophagoides farinae and pteronyss, olive, herb vitriol and Parietaria judaica were detected. Prick test were positive (ponf > 0.3 × 0.4 cm) for Dermatophagoides farinae and pteronyss, hair of dog, Parietaria and olive, thus confirming a multiple sensitivity. The patient showed a proper antibody specific response as demonstrated by the presence of IgG antibody serum levels, tested by immuno-enzymatic method, against B-hepatitis, parotitis and German measles viruses. Serum IgG, IgA e IgM levels were always in the normal range. The immunophenotype valuation revealed normal number and percentage of the lymphocyte subpopulations studied (Table 1).

Table 1. Immunonological parameters

The patient’s family history was notable for the presence of allergic disorders in both lineages. In particular, her mother and grandmother had a history of allergic rhinitis, while her father had urticaria. A maternal aunt died at 2 years of age by whooping-cough and a maternal uncle died at 16 months by a severe not better specified respiratory infection. A paternal aunt and her daughter had a history of allergic rhinitis.

We first determined the proliferative response of PBMC to CD3 cross-linking, that mimics in vivo antigen exposure, performed at optimal (1 ng/ml) or suboptimal (0.3 ng/ml) antibody concentration. The proliferation at the maximal dosage was significantly lower in the patient than in the controls (mean ± SE were: 800 ± 68 cpm and 29500 ± 3000 cpm in the proband and controls, respectively). Since a proper immune response to pathogens requires a Th1 induction and this process determines up-regulation of the expression of the IL-12R β2 chain, we evaluated mRNA expression of this molecule after mitogen stimulation of PBMC in vitro. No expression of IL-12R β2 transcript was found in patient’s cells (Figure 1A), differently from the controls. IL-12R β1 was expressed at normal levels (Figure 1B).

thumbnailFigure 1. mRNA expression of IL-12R β2 chain after mitogen stimulation of PBMC in vitro. (A) No expression of IL-12R β2 transcript was found in patient’s cells, differently from the controls. (B) IL-12R β1 was expressed at normal levels.

At molecular level, gene sequencing of IL-12R β2 gene revealed a missense mutation (G to A) at nucleotide 531 in the exon 5 in heterozygosity, resulting in the substitution of arginine (CGT) with histidine (CAT) in the extracellular domain of the receptor at the same aminoacid position 156 (designed R156H) (Figure 2). The mutation was not a polymorphism since was not found in 100 chromosomes from unrelated individuals. This G to A transition creates a new restriction site for NdeI enzyme (data not shown).

thumbnailFigure 2. gene sequencing of IL-12R β2 gene. At molecular level, gene sequencing of IL-12R β2 gene revealed a missense mutation (G to A) at nucleotide 531 in the exon 5 in heterozygosity, resulting in the substitution of arginine (CGT) with histidine (CAT) in the extracellular domain of the receptor at the same aminoacid position 156 (designed R156H).

Discussion

The case here reported indicates that alterations of the induction of a proper Th1 response may be associated with an atypical immunodeficiency characterized by high susceptibility to infections. The functional response of lymphocytes to IL-12 depends on the expression of a high affinity IL-12 receptor on Th1 and NK cells. The high affinity receptor for IL-12 consists of two subunits, β1 and β2, closely related to the cytokine receptor glycoprotein (gp) 130 [11,17]. The complete IL-12R is thought to be associated with the development, being expressed on human naive T cells during differentiation to Th1 but not to Th2. Therefore, the expression of these molecules is generally considered as a marker of Th1 dominated response [11-13,16]. Th1 cells produce IFN-gamma and IL-2 and, predominantly, promote cell mediate immune responses against intracellular pathogens [18,19]. In a previous study, we provided evidence of altered IL-12/IL-12R signaling in patients with very high IgE levels, suggestive of an impaired Th1 induction [20]. A defective induction of a Th1 response in patients may lead to a higher risk of infections, thus worsening the overall outcome of patients with very high IgE levels. In the case herein described a genetic alteration of the IL-12R β1 has been found in heterozygosity. Whether this alteration is really responsible for the phenotype remains to be definitively demonstrated with further molecular and functional studies. However, it should be noted that patients with homozygous alterations of the same gene have already been reported, being affected with a more severe clinical phenotype and selective susceptibility to mycobacterial infections [5,6]. Based on this clinical observation, we suggest that a better understanding of the molecular mechanisms governing Th1/Th2 homeostasis may help recognize novel clinical phenotypes of atypical immunodeficiencies.

Consent

Written informed consent was obtained from the parents of the patient for publication of this Case report and any accompanying images.

Abbreviations

IL-12: Interleukin-12; Th1: T helper 1; IFN-gamma: Interferon-gamma; NK: Natural Killer.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

LP has made substantial contributions to conception and design, has been involved in drafting the manuscript, and has given final approval of the version to be published. GG has made substantial contributions to conception and design, has been involved in drafting the manuscript, and has given final approval of the version to be published. FS has made substantial contributions to conception and design, has been involved in revising the manuscript critically for important intellectual content, and has given final approval of the version to be published. RR and AF has made substantial contributions to acquisition of data, has been involved in drafting the manuscript, and has given final approval of the version to be published. SM has made substantial contributions to acquisition of data, has been involved in revising the manuscript critically for important intellectual content, and has given final approval of the version to be published.

MVU has made substantial contributions to conception and design and analysis and interpretation of data, has been involved in revising the manuscript critically for important intellectual content, and has given final approval of the version to be published. CP has made substantial contributions to conception and design and analysis and interpretation of data, has been involved in drafting the manuscript and revising it critically for important intellectual content, and has given final approval of the version to be published.

References

  1. Palamaro L, Vigliano I, Giardino G, Cirillo E, Aloj G, Romano R, Pignata C: SCID-like phenotype associated with an inhibitory autoreactive immunoglobulin.

    J Investig Allergol Clin Immunol 2012, 22:67-70. PubMed Abstract OpenURL

  2. De Vries E, Alvarez Cardona A, Abdul Latiff AH, Badolato R, Brodszki N, Cant AJ, Carbone J, Casper JT, Ciznar P, Cochino AV, Conley ME, Derfalvi B, Driessen GJ, Elfeky R, Espanol T, Glimour K, Gueseva MN, Haverkamp MH, Helminen M, Honig M, Kanariou MG, Kirschfink M, Klein C, Kuijpers TW, Kutukculer N, Martire B, Meyts I, Niehues T, Pignata C, Reda SM, Renner ED, Rezaei N, Rizzi M, Sampalo Lainz MA, Sargur RB, Sediva A, Seidel MG, Seneviratne SL, Soler-Palacin P, Tommasini A, Warnatz K: Patient-centred screening for primary immunodeficiency, a multi-stage diagnostic protocol designed for non-immunologists: 2011 update.

    Clin Exp Immunol 2012, 167:108-119. PubMed Abstract | Publisher Full Text OpenURL

  3. Aloj G, Giardino G, Valentino L, Maio F, Gallo V, Esposito T, Naddei R, Cirillo E, Pignata C: Severe combined immunodeficiences: new and old scenarios.

    Int Rev Immunol 2012, 31:43-65. PubMed Abstract | Publisher Full Text OpenURL

  4. Aytekin C, Dogu F, Tuygun N, Tanir G, Guloglu D, Boisson-Dupuis S, Bustamante J, Feinberg J, Casanova JL, Ikinciogullari A: Bacille Calmette-Guèrin lymphadenitis and recurrent oral candidiasis in an infant with a new mutation leading to interleukin-12 receptor beta-1 deficiency.

    J Invest Allergol Clin Immunol 2011, 21:401-404. OpenURL

  5. Pedraza-Sanchez S, Herrera-Barrios MT, Aldana-Vergara R, Neumann-Ordoez M, Gonzalez-Hernandez Y, Sada-Dìaz E, de Beaucoudrey L, Casanova JL, Torres-Rojas M: Bacille Calmette-Guèrin infection and disease with fatal outcome associated with a point mutation in the interleukin-12/interleukin-23 receptor beta-1 chain in two Mexican families.

    Int J Infect Dis 2010, 14:e256-e260. PubMed Abstract | Publisher Full Text OpenURL

  6. Shah P, El-Maaytah M, Jerjes W, Upile T, Ayliffe P: Interleukin 12 receptor beta1 chain deficiency in a child with disseminated tuberculosis: a case report.

    J Oral Maxillofac Surg 2010, 68:909-911. PubMed Abstract | Publisher Full Text OpenURL

  7. Granados EL, Porpiglia AS, Hogan MB, Matamoros N, Krasovec S, Pignata C, Smith CIE, Hammarstrom L, Bjorkander J, Belohradsky BH, Fontan Casariego G, Garcia Rodriguez MC, Conley ME: Clinical and molecular analysis of patients with defects in micro heavy chain gene.

    J Clin Invest 2002, 110:1029-1035. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  8. Altare F, Durandy A, Lammas D, Emile JF, Lamhamedi S, Le Deist F, Drysdale P, Jouanguy E, Doffinger R, Bernaudin F, Jeppsson O, Gollob JA, Meinl E, Segal AW, Fischer A, Kumararatne D, Casanova JL: Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency.

    Science 1998, 280:1432-1435. PubMed Abstract | Publisher Full Text OpenURL

  9. Sakai T, Matsuoka M, Aoki M, Nosaka K, Mitsuya H: Missense mutation of the interleukin-12 receptor beta1 chain-encoding gene is associated with impaired immunity against Mycobacterium avium complex infection.

    Blood 2001, 97:2688-2694. PubMed Abstract | Publisher Full Text OpenURL

  10. Presky DH, Yang H, Minetti LJ, Chua AO, Nabavi N, Wu CY, Gately MK, Gubler U: A functional interleukin 12 receptor complex is composed of two β-type cytokine receptor subunits.

    Proc Natl Acad Sci USA 1996, 93:14002-14007. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  11. Rogge L, Barberis-Maino L, Biffi M, Passini N, Presky DH, Gubler U, Sinigaglia F: Selective expression of an interleukin-12 receptor component by human T helper 1 cells.

    J Exp Med 1997, 185:825-831. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  12. Szabo SJ, Dighe AS, Gubler U, Murphy KM: Regulation of the interleukin (IL) -12RB2 subunit expression in developing T helper 1 (Th1) and Th2 cells.

    J Exp Med 1997, 185:817-824. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  13. Gately MK, Renzetti LM, Magram J, Stern AS, Adorini L, Gubler U, Presky DH: The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses.

    Annu Rev Immunol 1998, 16:495-521. PubMed Abstract | Publisher Full Text OpenURL

  14. Amorosi S, Russo I, Amodio G, Garbi C, Vitiello L, Palamaro L, Adriani M, Vigliano I, Pignata C: The cellular amount of the common γ-chain influences spontaneous or induced cell proliferation.

    J Immunol 2009, 182:3304-3309. PubMed Abstract | Publisher Full Text OpenURL

  15. Vigliano I, Palamaro L, Bianchino G, Fusco A, Vitiello L, Grieco V, Romano R, Salvatore M, Pignata C: Role of the common g chain in cell cycle progression of human malignant cell lines.

    Int Immunol 2012, 24:159-167. PubMed Abstract | Publisher Full Text OpenURL

  16. Montella S, Maglione M, Bruzzese D, Mollica C, Pignata C, Aloj G, Manna A, Esposito A, Mirra V, Santamaria F: Magnetic resonance imaging is an accurate and reliable method to evaluate non-cystic fibrosis paediatric lung disease.

    Respirology 2012, 17:87-91. PubMed Abstract | Publisher Full Text OpenURL

  17. Presky DH, Minetti LJ, Gillessen S, Wilkinson VL, Wu CY, Gubler U, Chizzonite R, Gately MK: Analysis of the multiple interactions between IL-12 and the high affinity IL-12 receptor complex.

    J Immunol 1998, 160:2174-2179. PubMed Abstract | Publisher Full Text OpenURL

  18. Santoni D, Pedicini M, Castiglione F: Implementation of a regulatory gene network to simulate the TH1/2 differentiation in an agent-based model of hypersensitivity reactions.

    Bioinformatics 2008, 24:1374-1380. PubMed Abstract | Publisher Full Text OpenURL

  19. Finkelman FD, Vercelli D: Advances in asthma, allergy mechanisms, and genetics in 2006.

    J Allergy Clin Immunol 2007, 120:544-550. PubMed Abstract | Publisher Full Text OpenURL

  20. Fusco A, Vigliano I, Palamaro L, Cirillo E, Aloj G, Piscopo G, Giardino G, Pignata C: Altered signaling through IL-12 receptor in children with very high serum IgE levels.

    Cell Immunol 2010, 265:74-79. PubMed Abstract | Publisher Full Text OpenURL